Risk Stratification
Delirium risk models combine age, cognitive baseline, sedation exposure, and metabolic factors to identify patients whose screening should be prioritized during a shift.
Custom Software
AI Delirium Prediction Software Development
AI delirium prediction software applies machine learning to medication records, sedation data, mobility status, and assessment history to identify patients warranting formal delirium screening. It functions as decision support only: the nurse performs every assessment and the prescriber makes all medication decisions.
Delirium is common, consequential, and routinely under-detected, largely because formal screening competes with everything else during a shift. Taction Software builds AI delirium prediction tooling that targets screening effort toward patients most likely to be affected, and surfaces contributing medications for pharmacist and prescriber review.
Tell Us Your Requirements
Our experts are ready to understand your business goals.
Trusted Partners
Trusted by Industry Leaders Worldwide
Recognition
Awards & Recognitions
What Is AI Delirium Prediction Software
AI delirium prediction refers to machine learning applied to sedation exposure, deliriogenic medication use, sleep disruption, immobility, restraint use, and prior assessment results to estimate delirium risk and prompt formal screening. The software does not diagnose delirium. Diagnosis requires a bedside assessment such as CAM or CAM-ICU performed by a trained clinician, and the tool exists to make sure that assessment happens for the right patients at the right time. This work sits inside our broader healthcare AI practice, where validation and regulatory classification are engineering deliverables.
Screening Prompt Delivery
CAM-ICU and CAM screening prompts are delivered into nursing workflow at appropriate intervals. The nurse performs and interprets every assessment personally.
Deliriogenic Medication Review
Deliriogenic medications including anticholinergics and benzodiazepines are flagged for pharmacist and prescriber review, who make all medication decisions.
Sedation and Sleep Context
Sedation depth and sleep disruption data are surfaced alongside risk, since both are modifiable contributors the care team can address directly.
Mobility and Restraint Context
Immobility and restraint use are surfaced as contributing factors, supporting mobility and restraint reduction efforts led by the clinical team.
Decision Support Boundaries
Every output carries clinical decision support framing. The software does not diagnose delirium, adjust sedation, discontinue medication, or make care decisions in any configuration.
Core AI Delirium Prediction Services
Our AI delirium prediction services cover data integration, risk modeling, screening workflow, medication review routing, and monitoring. Delirium projects live or die on nursing workflow fit, because the intervention is an assessment performed by a nurse who is already busy. A prompt that arrives at the wrong moment or too often produces documented non-completion rather than improved detection. Engagements typically open with a review of current screening compliance, nursing workflow, and available medication and sedation data. Deliverables are structured so nursing leadership, pharmacy, and IT stakeholders can review independently.
01
Data Integration and Assembly
We assemble medication administration, sedation, mobility, and assessment data, handling the data linkage work that determines whether risk modeling is feasible at all.
02
Risk Model Development
Development produces risk stratification validated on your population, with performance reported by age, baseline cognition, and admission type rather than aggregate.
03
Screening Workflow Design
We design prompt timing and volume with nursing leadership, since a screening prompt arriving during medication pass will be dismissed regardless of accuracy.
04
Medication Review Routing
Flagged medication regimens route to pharmacy for review, connecting with AI medication reconciliation workflows where the prescriber decides.
05
EHR Integration
Prompts and results must appear in nursing documentation. Our EHR and EMR integration practice covers flowsheet integration and write-back.
06
Evaluation and Monitoring
Ongoing evaluation draws on our healthcare AI evaluation services practice, tracking screening completion alongside model performance.
Benefits of AI Delirium Prediction Software
The benefits of AI delirium prediction concentrate in targeted screening effort, visible modifiable contributors, and structured data for quality review. Universal screening is the guideline ideal and the practical exception, so directing effort toward higher-risk patients is often the difference between some screening and none. Surfacing deliriogenic medications also gives pharmacy a concrete review list. We publish no figures on delirium incidence, detection rates, or length of stay, because those depend entirely on your population and current practice. What we deliver is instrumentation.
Targeted Screening Effort
Risk stratification directs screening prompts toward patients most likely to be affected, which matters where universal screening compliance is realistically unattainable.
Visible Modifiable Factors
Surfacing sedation, sleep, and mobility contributors gives the team actionable targets rather than a risk score with no obvious response.
Concrete Medication Review Lists
Flagged high-risk medications give pharmacy a specific review queue, supporting deprescribing conversations that the prescriber leads and decides.
Better Geriatric Care Coordination
Risk data supports coordinated care for older inpatients, connecting with geriatrics AI workflows for frailty context.
Structured Quality Data
Consistent screening and outcome capture makes quality review measurable, showing which units complete screening and for which patients it was skipped.
Acuity Planning Context
Delirium risk informs staffing discussion alongside AI patient acuity scoring, where staffing decisions are made by nursing leadership.
Our AI Delirium Prediction Process
We deliver AI delirium prediction projects in gated phases so clinical stakeholders approve direction before engineering cost accumulates. Discovery establishes intended use, data availability, current screening compliance, and regulatory classification. Because the intervention is nursing assessment, we design prompt timing and volume with bedside nurses rather than only nursing leadership, since the people receiving prompts know when they can act on them. Deployment runs silent first so risk stratification can be compared against documented assessment results.
Discovery and Compliance Baseline
Discovery defines intended use, measures current screening compliance, and identifies which contributing data is reliably available in structured form.
Data Assessment and Preparation
We evaluate medication administration, sedation, and mobility data completeness, since sparse documentation of modifiable factors limits what any model can detect.
Model Development and Validation
Development runs to held-out validation with performance reported by age, baseline cognition, and admission type, plus subgroup review for equity.
Prompt Design With Bedside Staff
We design prompt timing with bedside nurses, because alert volume and timing determine completion far more than model discrimination does.
Silent Mode Evaluation
The model runs in silent deployment, comparing risk against documented assessment outcomes so stratification quality is confirmed before prompts appear.
Rollout and Ongoing Support
Rollout expands unit by unit with completion dashboards, nursing governance review, and continuing monitoring for the life of the deployment.
Technology and Compliance
Delirium prediction handles PHI including medication, sedation, and cognitive assessment data. Taction holds ISO 27001 certification and follows HIPAA-aligned engineering practice. Where risk output is intended to guide clinical management, SaMD classification may apply. The practical concern specific to this category is alert burden: delirium prompts land on nurses who already receive many alerts, and a system that increases dismissal rates without increasing completed assessments has made things worse while appearing to add capability.
HIPAA-Aligned Engineering
Builds apply encryption in transit and at rest, role-based access, and complete audit logging. Our HIPAA compliance software development practice defines these controls.
SaMD and FDA Considerations
Risk output guiding management may trigger SaMD classification. Our FDA SaMD compliance services cover design history, validation, and change control.
Alert Burden Management
Alert burden is modeled before go-live and tracked afterward, with completion rates monitored alongside accuracy so added prompts demonstrably produce added assessments.
Cognitive Data Sensitivity
Cognitive assessment data carries stigma risk and requires careful access control, particularly where results persist in the record beyond the acute episode.
Validation and Bias Monitoring
Validation reports performance by age, cognitive baseline, and language, with bias monitoring, since assessment instruments themselves perform unevenly across language groups.
Deployment Security
Deployments run on-premise, in your cloud tenancy, or hybrid, with network segmentation, signed container images, and documented penetration testing before release.
Why Choose Taction Software
Taction Software was founded in 2013 and has spent over 12 years building healthcare software, delivering more than 200 healthcare projects from four US offices in Chicago, Cheyenne, Austin, and Sacramento, with ISO 27001 certification. Our relevant strength here is designing for nursing workflow rather than around it. Delirium tooling succeeds or fails on whether a busy nurse can act on a prompt, and we treat prompt design as a clinical deliverable requiring bedside input. Our leadership brings more than 20 years of personal experience in the field.
01
Nursing Workflow Design
We design prompt timing with bedside nurses rather than only leadership, because the people receiving alerts know when action is actually possible.
02
Established Healthcare Focus
Founded in 2013, we have concentrated on healthcare rather than treating it as one vertical among several, producing depth in clinical workflow and documentation systems.
03
EHR and Clinical Systems Depth
Our Voyant Health EHR and EMR work means flowsheet integration and prompt delivery are handled by engineers with clinical systems experience.
04
Regulated Product Experience
We delivered the FDA-registered applications Revive Ease and PainKare, so design controls and validation documentation are established practice.
05
Decision Support Engineering
We build clinical decision support with clinician authority preserved, detailed in our clinical decision support software development practice.
06
Certified Security Posture
ISO 27001 certification and HIPAA-aligned engineering mean security controls are documented and auditable, supporting your vendor risk assessment efficiently.
Pricing
AI delirium prediction pricing depends on scope, data availability, unit count, and whether medication review routing is in scope. A risk stratification module using existing structured data costs considerably less than a system integrating sedation streams, medication review workflow, and multi-unit prompt delivery. We price after discovery, because documentation completeness for modifiable factors varies widely and drives feasibility. Discovery produces an itemized, fixed-scope estimate with phase-level breakdown. Cloud infrastructure and third-party licensing are separate from engineering and itemized clearly.
MVP or Single Module
An MVP covering risk stratification and prompt delivery on one unit typically runs $40,000 to $80,000, validating workflow fit before broader commitment.
Full Platform Build
A full platform with sedation integration, medication review routing, multi-unit prompts, and monitoring typically falls between $80,000 and $200,000.
Enterprise Deployment
Enterprise engagements covering multi-facility rollout, custom modeling, validation, and regulatory documentation start at $200,000 and scale with unit count.
Discovery Phase Scoping
Discovery is a paid, time-boxed phase producing an itemized estimate, architecture plan, and screening compliance baseline. It is separable so you can evaluate our work first.
Cost Drivers to Expect
Data completeness, sedation stream integration, unit count, and medication review scope are the largest variables, each identified during discovery for budget planning.
Ongoing Support Costs
Post-launch alert tuning, recalibration, completion monitoring, and support are quoted separately as a retainer sized to your unit count.
Get Started
If you are evaluating AI delirium prediction for screening prioritization, medication review, or ICU and geriatric workflow, the fastest next step is a discovery call with our clinical engineering team. We will review your screening compliance, available data, and nursing workflow, then return an itemized, fixed-scope estimate. Contact us to schedule that conversation.
FAQs
Frequently Asked Questions
Hospitals evaluating AI delirium prediction usually ask whether the software diagnoses delirium, how prompt burden is controlled, and whether medication flagging interferes with prescribing. The answers below reflect how we scope these projects. If your scope spans ICU and general wards, note that model inputs and screening cadence differ substantially between them.
No. Diagnosis requires a bedside assessment such as CAM or CAM-ICU performed and interpreted by a trained clinician. The software identifies patients whose screening should be prioritized and prompts that assessment. It does not diagnose, and a high risk score is explicitly not a delirium finding.
By designing prompt timing and volume with bedside nurses before launch, modeling expected alert load against historical data, and tracking completion rates afterward. If added prompts do not produce added completed assessments, the configuration is wrong and we tune it rather than reporting accuracy in isolation.
No. Deliriogenic medications are flagged for pharmacist and prescriber review, and sedation depth is surfaced as context. Every medication and sedation decision remains with the prescriber. The software does not discontinue medication, adjust sedation, or place orders in any configuration.
An MVP covering one unit runs $40,000 to $80,000. A full platform typically falls between $80,000 and $200,000. Enterprise multi-facility deployments start at $200,000. Discovery produces an itemized, fixed-scope estimate, with infrastructure quoted separately from engineering.
Usually not well. ICU risk is dominated by sedation and ventilation, while ward risk weights baseline cognition and medication burden more heavily. We build population-specific models where the data supports it, rather than applying one model and accepting degraded performance on one side.
With restricted access and audit logging, treated as sensitive given the stigma associated with cognitive impairment and the fact that these results persist in the record. Access is scoped to clinicians involved in care rather than exposed broadly across the enterprise record.